SLRN
Price:
$5.82
Market Cap:
$580.88M
Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody against insulin-like growth factor 1 receptor, which is in Phase 1 clinical trials for use in the treatm...[Read more]
Industry
Biotechnology
IPO Date
2023-05-04
Stock Exchange
NASDAQ
Ticker
SLRN
According to Acelyrin, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.86. This represents a change of -24.36% compared to the average of 10.39 of the last 4 quarters.
The mean historical Current Ratio of Acelyrin, Inc. over the last ten years is 9.14. The current 7.86 Current Ratio has changed 8.50% with respect to the historical average. Over the past ten years (40 quarters), SLRN's Current Ratio was at its highest in in the June 2023 quarter at 25.34. The Current Ratio was at its lowest in in the March 2022 quarter at 0.
Average
9.14
Median
8.71
Minimum
8.65
Maximum
10.06
Discovering the peaks and valleys of Acelyrin, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 15.43%
Maximum Annual Current Ratio = 10.06
Minimum Annual Increase = -14.00%
Minimum Annual Current Ratio = 8.65
Year | Current Ratio | Change |
---|---|---|
2023 | 8.65 | -14.00% |
2022 | 10.06 | 15.43% |
The current Current Ratio of Acelyrin, Inc. (SLRN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.14
5-year avg
9.14
10-year avg
9.14
Acelyrin, Inc.’s Current Ratio is
Company | Current Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acelyrin, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acelyrin, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Acelyrin, Inc.'s Current Ratio?
How is the Current Ratio calculated for Acelyrin, Inc. (SLRN)?
What is the highest Current Ratio for Acelyrin, Inc. (SLRN)?
What is the 3-year average Current Ratio for Acelyrin, Inc. (SLRN)?
What is the 5-year average Current Ratio for Acelyrin, Inc. (SLRN)?
How does the current Current Ratio for Acelyrin, Inc. (SLRN) compare to its historical average?